Aptose Biosciences Inc. announced the rescheduling of its special meeting of shareholders originally set for January 16, 2026.
The meeting will be postponed to a later date due to awaiting final clearance from the SEC for the acquisition by Hanmi.
No changes are expected in the record date or matters to be presented to shareholders at the meeting.
Rescheduled Meeting
The special meeting of shareholders to approve the acquisition by Hanmi is being postponed to a later date due to awaiting final SEC clearance.
Record Date
The record date for the meeting remains unchanged, set for the close of business on December 12, 2025.
Recommendation
Aptose's board unanimously recommends shareholders to vote FOR the special resolutions approving the Continuance and the Arrangement.
- The rescheduling of the meeting indicates the importance of receiving final SEC clearance for the acquisition by Hanmi to proceed smoothly.
- Shareholders are advised to stay updated for the announcement of the new meeting date, time, and virtual details.
Aptose Biosciences anticipates a successful acquisition by Hanmi pending final clearance from the SEC, urging shareholders to support the special resolutions.